Literature DB >> 28066598

Left thoracotomy for middle or lower thoracic esophageal carcinoma: still Sweet enough?

Zhi-Qiang Wang1, Wen-Ping Wang2, Yong Yuan2, Yang Hu2, Jun Peng2, Yun-Cang Wang2, Long-Qi Chen2.   

Abstract

BACKGROUND: Esophagectomy via left thoracotomy (the Sweet procedure) has long been the conventional route for resection of esophageal carcinoma, especially in China. However, this procedure is being increasingly critiqued, mainly regarding the lymphadenectomy. The objective of this study was to compare the Sweet procedure with the right upper mediastinal lymph node resection (MS) and Ivor-Lewis (IL) procedure in the treatment of middle or lower thoracic esophageal squamous cell carcinoma (OSCC-MLT) in terms of lymphadenectomy, postoperative complications, and long-term survival.
METHODS: A total of 336 OSCC-MLT patients underwent radical intent surgery (188 with MS and 148 with IL procedure) between January 2007 and September 2013 in our hospital. After propensity score matching, 129 patients from each procedure were included. The efficacy of lymph node dissection at each station was estimated by the index of estimated benefit from lymph node dissection (IEBLD).
RESULTS: IEBLD is relatively high in stations 2L, 2R, 8, 16 and 17. The metastasis rates and ratios were similar between the MS and IL procedures at each station. The MS procedure significantly outperformed the IL procedure with a shorter operating time (212 vs. 317 min), shorter in-hospital stay (10.7 vs. 15.3 days), and fewer postoperative complications (30.2% vs. 43.4%). However, the 5-year survival rates were not significantly different between the two procedures (46.9% vs. 44.0%).
CONCLUSIONS: The MS procedure of esophagectomy is not inferior to the IL procedure in efficiency, moreover the MS procedure is safer.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; lymph node; lymphadenectomy; sweet

Year:  2016        PMID: 28066598      PMCID: PMC5179454          DOI: 10.21037/jtd.2016.11.62

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  27 in total

1.  Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies.

Authors:  Po-Kuei Hsu; Chien-Sheng Huang; Chih-Cheng Hsieh; Yu-Chung Wu; Wen-Hu Hsu
Journal:  Surgery       Date:  2014-06-19       Impact factor: 3.982

2.  Transthoracic versus Transhiatal esophagectomy: a permanent dilemma. our 15-year experience.

Authors:  R M Neagoe; D Sala; S Voidazan; S Bancu; L Kiss; H Suciu
Journal:  Chirurgia (Bucur)       Date:  2013 Nov-Dec

3.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

4.  Esophagectomy in esophageal cancer - is there an optimal approach?

Authors:  N Dănilă; C Lupaşcu; M Andronic; M Costache; O Dumitaş; A Plesa; M Blaj; O Apopei
Journal:  Chirurgia (Bucur)       Date:  2014 Sep-Oct

5.  Subtotal esophagectomy with extended 2-field lymph node dissection for thoracic esophageal cancer.

Authors:  Ivan Stilidi; Michail Davydov; Vahan Bokhyan; Elkhan Suleymanov
Journal:  Eur J Cardiothorac Surg       Date:  2003-03       Impact factor: 4.191

6.  The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.

Authors:  J Morimoto; H Tanaka; M Ohira; N Kubo; K Muguruma; K Sakurai; Y Yamashita; K Maeda; T Sawada; K Hirakawa
Journal:  Dis Esophagus       Date:  2013-03-08       Impact factor: 3.429

7.  Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy.

Authors:  Joyce Wong; Jill Weber; Khaldoun Almhanna; Sarah Hoffe; Ravi Shridhar; Richard Karl; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-07-02       Impact factor: 3.452

8.  Extended lymphadenectomy in esophageal cancer is debatable.

Authors:  Fernando A M Herbella; Rafael M Laurino Neto; Marco E Allaix; Marco G Patti
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

9.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

10.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Authors:  Peter C Austin
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

View more
  5 in total

Review 1.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Comparison of Ivor Lewis and Sweet esophagectomy for middle and lower esophageal squamous cell carcinoma: A systematic review and pooled analysis.

Authors:  Yuhang Xue; Donglai Chen; Wei Wang; Wenjia Wang; Lei Chen; Yonghua Sang; Yongbing Chen; Weihua Xu
Journal:  EClinicalMedicine       Date:  2020-10-10

3.  Comparison of Long-term Quality of Life in Patients with Esophageal Cancer after Ivor-Lewis, Mckeown, or Sweet Esophagectomy.

Authors:  Yu-Shang Yang; Qi-Xin Shang; Yong Yuan; Xiao-Ying Wu; Wei-Peng Hu; Long-Qi Chen
Journal:  J Gastrointest Surg       Date:  2018-10-08       Impact factor: 3.452

4.  Comparison of Ivor Lewis esophagectomy and Sweet esophagectomy for the treatment of middle-lower esophageal squamous cell carcinoma.

Authors:  Yuan Feng; Nan Wu; Shi Yan; Xing Wang; Yue Yang
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

5.  Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma.

Authors:  Hansheng Wu; Weitao Zhuang; Shujie Huang; Xueting Guan; Yuju Zheng; Zefeng Xie; Gang Chen; Jiming Tang; Haiyu Zhou; Liang Xie; Xiaosong Ben; Zihao Zhou; Zijun Li; Rixin Chen; Guibin Qiao
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.